← Open Payments lookup

CAITLIN WILLSIE: Open Payments

NPI 1093209686 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$513 in 29 payments from 14 companies in 2025. Trend: 2023 $537 · 2024 $483 · 2025 $513

Food & beverage: $513
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP4$81
Dexcom, Inc.4$78
Astellas Pharma US Inc4$57
Boehringer Ingelheim Pharmaceuticals, Inc.3$52
Novo Nordisk Inc2$40
SHIELD THERAPEUTICS INC2$37
ABBVIE INC.2$34
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$29
Exact Sciences Corporation1$21
Lilly USA, LLC1$19

Products named: AIRSUPRA, Dexcom G6 Transmitter, Veozah, JARDIANCE, ACCRUFER, QULIPTA, XIFAXAN, Ozempic.

Industry payments across LA — which companies pay providers there.